NCT05265091View on ClinicalTrials.gov

A Study of KL590586 in Patients With Advanced Solid Tumors

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

414

Participants

Timeline

Start Date

June 1, 2021

Primary Completion Date

May 30, 2025

Study Completion Date

May 30, 2025

Conditions
Advanced Solid Tumor
Interventions
DRUG

KL590586 Capsule

Product Name: KL590586 Capsules Formulation：Capsule Specification: 10mg; 50mg Ingredients: KL590586, microcrystalline cellulose, mannitol, cross-linked sodium carboxymethylcellulose, colloidal silicon dioxide, magnesium stearate, hydroxypropylmethylcellulose hollow capsule

Trial Locations (1)

610000

Sichuan Kelun Botai Biopharmaceutical Co., Chengdu

All Listed Sponsors
lead

Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

INDUSTRY